nct_id: 'OBI-822-011-UW18-484'
age: Adults
cancer_center_accrual_goal_upper: 0
data_table4: 'Interventional'
drug_list:
  drug:
    - drug_name: 'Adagloxad Simolenin'
    - drug_name: 'OBI-821'
long_title: 'The GLORIA Study: A Phase 3, Randomized, Open-Label Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients with High-Risk, Early-Stage Globo H-Positive Triple Negative Breast Cancer'
management_group_list:
  management_group:
  - is_primary: Y
    management_group_name: HKUMed
oncology_group_list:
  oncology_group:
  - group_name: Group 1
    is_primary: N
phase: '3'
principal_investigator: 'Dr Wendy CHAN'
principal_investigator_institution: HKU
program_area_list:
  program_area:
  - is_primary: Y
    program_area_name: Program 1
protocol_id: 
protocol_no: ''
protocol_target_accrual: 0
protocol_type: ""
prior_treatment_requirements: 
  - 'Histologically documented TNBC (ER/PR ≤5% cells)'
  - 'High risk deﬁned as: ≥1 cm residual primary or ≥1 residual axillary node after neoadjuvant chemotherapy OR Pathological Stage IIB or III disease treated with adjuvant chemotherapy alone'
  - 'Received ≥4 cycles of standard taxane- and/or anthracycline-based chemotherapy'  
short_title: 'Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients with Triple Negative Breast Cancer'
site_list:
 site: []
sponsor_list:
 sponsor: []
staff_list:
 protocol_staff: []
status: open to accrual
summary: ''
treatment_list:
  step:
  - arm:
    - arm_code: Arm A
      arm_internal_id: 1111
      arm_description: 'Treatment with Adagloxad Simolenin + OBI-821'
      arm_suspended: N  
    - arm_code: Arm B
      arm_internal_id: 2222
      arm_description: 'SOC'
      arm_suspended: N 
    step_code: '1'
    step_type: 'Registration'
    step_internal_id: 1111
    match:
        - and:
          - clinical:              
              oncotree_primary_diagnosis: 'Invasive Breast Carcinoma'
              her2_status: 'Negative'
              er_status: 'Negative'
              pr_status: 'Negative'
              